# GlaxoSmithKline LLC – FDA Inspection, Nov 1, 2012

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/6a59303c-a690-4300-8bae-39abb1bffe78
Source feed: FDA_Inspections

> FDA inspection 805603 of GlaxoSmithKline LLC, November 01, 2012. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 805603
- Company Name: GlaxoSmithKline LLC
- Inspection Date: 2012-11-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1269601 - 2025-10-21
- FDA Inspection 1253764 - 2024-11-22
- FDA Inspection 1187325 - 2022-10-24
- FDA Inspection 1180594 - 2022-08-12
- FDA Inspection 886173 - 2014-06-03

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/b0586c5b-ed04-498a-befc-515b46a93b3a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c